Clinical Evaluation on Amavata (Rheumatoid Arthritis) Management with Amavatari Ras and Brihat saindyabadi taila
1 Research Officer (Ayurveda), Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India
2 Director, Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India
Corresponding Author:Saroj Kumar Debnath
45 Amavata (Rheumatoid arthritis) patients had been selected from the O.P.D. & I.P.D. of Central Ayurveda Research Institute for Drug Development, Kolkata for the clinical study. 40 patients were completed the treatment out of 45 and 5 patients were dropped out from the study before completion of the treatment. The objective of the study was to evaluate the safety and efficacy of selected Ayurvedic medicines on the management of Amavata (Rheumatoid arthritis) during study. The treatment schedule was that 250 mg Amavatari Ras (Ayurvedic pill medicine) orally thrice in a day after meal with warm water for 30 days & Brihat saindyabadi taila (Ayurvedic oil medicine) applied locally over affected joints twice in a day for 30 days. In present clinical study 35 % patients got major improvement, 50% patients got minor improvement, 10% patients showed no improvement and complete remission was nil. No adverse drug reaction was observed during the study.
sellKeywords
How to Cite
Debnath, S. K., Barik, L., Sahu, D., & Hazra, J. (2020). Clinical Evaluation on Amavata (Rheumatoid Arthritis) Management with Amavatari Ras and Brihat saindyabadi taila. International Journal of Ayurvedic and Herbal Medicine, 10(1). https://doi.org/10.31142/ijahm/v10i1.06
American Psychological Association Style
